Cited by 1,343Alzheimer's disease research and treatmentsCellular transport and secretionExtracellular vesicles in disease

Alzheimer’s disease β-amyloid peptides are released in association with exosomes

Open access
Rajendran, Lawrence, Honsho, Masanori, Zahn, Tobias R., Keller, Patrick, Geiger, Kathrin D., Verkade, Paul, Simons, Kai·2006·Proceedings of the National Academy of Sciences

Abstract

Although the exact etiology of Alzheimer's disease (AD) is a topic of debate, the consensus is that the accumulation of β-amyloid (Aβ) peptides in the senile plaques is one of the hallmarks of the progression of the disease. The Aβ peptide is formed by the amyloidogenic cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. The endocytic system has been implicated in the cleavages leading to the formation of Aβ. However, the identity of the intracellular compartment where the amyloidogenic secretases cleave and the mechanism by which the intracellularly generated Aβ is released into the extracellular milieu are not clear. Here, we show that β-cleavage occurs in early endosomes followed by routing of Aβ to multivesicular bodies (MVBs) in HeLa and N2a cells. Subsequently, a minute fraction of Aβ peptides can be secreted from the cells in association with exosomes, intraluminal vesicles of MVBs that are released into the extracellular space as a result of fusion of MVBs with the plasma membrane. Exosomal proteins were found to accumulate in the plaques of AD patient brains, suggesting a role in the pathogenesis of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0603838103

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Coordinated defects in ciliary signaling and intracellular trafficking may collectively facilitate extracellular vesicle and tunneling nanotube-dependent propagation of neurotoxic proteins across neural networks, potentially reinforcing progressive circuit dysfunction.

    “These coordinated defects in ciliary signaling and intracellular trafficking may collectively facilitate the EV and TNT-dependent propagation of neurotoxic proteins across neural networks, thereby potentially reinforcing progressive circuit dysfunction (Figure 3A) [98,100,101,105].”

    From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [98]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Amyloid-beta and tau propagate to other neurons via tunneling nanotubes and exosomes.

    “Ultimately, Aβ and tau propagate to other neurons via TNT and exosomes [98,99,100,101].”

    From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [98]

    The Discussion reports that a minute fraction of Aβ is released with exosomes and suggests that Aβ could use exosomes for intercellular transfer. It does not establish propagation to other neurons, and the passages do not address tau or tunneling nanotubes. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • These pathway alterations enhance extracellular vesicle-mediated export of pathogenic proteins including amyloid-beta and tau, facilitating their propagation between cells.

    “These pathway alterations enhance the EV-mediated export of pathogenic proteins, including Aβ and tau, facilitating their propagation between cells [98,99].”

    From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [98]

    The Discussion (page not provided) reports that a minute fraction of Aβ is secreted in association with exosomes and proposes that exosomes could mediate its transfer between cells. It does not report EV-mediated tau export or establish that the pathway alterations described in the citing sentence enhance export and propagation. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • Exosomes isolated from the brain, CSF, and plasma of AD patients and/or AD animal models contain pathologic Aβ and tau.

    “Exosomes isolated from the brain, cerebrospinal fluid (CSF), and plasma of AD patients and/or AD animal models contain pathologic Aβ and tau [73, 75–77].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Kojro, E., Gimpl, G., Lammich, S., Marz, W. & Fahrenholz, F. (2001) Proc. Natl. Acad. Sci. USA 98, 5815-5820.
  2. Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., Laude, H. & Raposo, G. (2004) Proc. Natl. Acad. Sci. USA 101, 9683-9688.

Cited by

Sorted by citations

Authors
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K.
Affiliations
  • Max Planck Institute of Molecular Cell Biology and Genetics (DE)
  • Meso Scale Discovery (United States) (US)
  • Technische Universität Dresden (DE)
Venue
Proceedings of the National Academy of Sciences
Published
2006-07-25
Volume
103
Issue
30
Pages
11172-11177
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2156281143
Cited by
1,343
References
54
Citations by year
2026: 59 · 2025: 50 · 2024: 85 · 2023: 80 · 2022: 98 · 2021: 114 · 2020: 115 · 2019: 116 · 2018: 83 · 2017: 86 · 2016: 90 · 2015: 67 · 2014: 48 · 2013: 58 · 2012: 61
FWCI
12.81
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
  • Explore Bristol Research (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
Alzheimer's disease, amyloid-beta, exosomes, multivesicular bodies, early endosomes, amyloid precursor protein, beta-secretase, gamma-secretase, amyloid plaques, exosomal proteins, endosomal trafficking
MeSH terms
Adenoviridae, Alzheimer Disease, Animals, Brain, Cell Membrane, Cell Nucleus, Endocytosis, Exoribonucleases, HeLa Cells, Humans, Models, Biological, Peptides, Amyloid beta-Peptides, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review